These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6974039)

  • 1. Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen.
    Kirkwood JM; Canellos GP; Ervin TJ; Pitman SW; Weichselbaum R; Miller D
    Cancer; 1981 May; 47(10):2414-21. PubMed ID: 6974039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial adjuvant therapy in advanced squamous cell carcinoma of the head and neck employing weekly high dose methotrexate with leucovorin rescue.
    Pitman SW; Miller D; Weichselbaum R
    Laryngoscope; 1978 Apr; 88(4):632-8. PubMed ID: 306011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer.
    Taylor SG; McGuire WP; Hauck WW; Showel JL; Lad TE
    J Clin Oncol; 1984 Sep; 2(9):1006-11. PubMed ID: 6332178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
    Inuyama Y; Hiroto I; Taketa C; Horiuchi M; Mashino S; Fujii M; Matsuura S; Satake B; Takeoda S; Nishijima W; Okuda M; Sakaguchi K; Tanigaito Y; Imakirei M; Konno T; Hirokawa T; Takada K; Ono I; Saitoh H; Takemiya S; Shimada F; Omura K; Miyake H; Fujii K; Kawabe Y; Kondoh T; Komiyama S; Yanagida T; Matsumura Y; Hirano M; Araki S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2193-200. PubMed ID: 6764099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
    Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
    Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer.
    DeConti RC; Schoenfeld D
    Cancer; 1981 Sep; 48(5):1061-72. PubMed ID: 7023649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
    Browman GP; Goodyear MD; Levine MN; Russell R; Archibald SD; Young JE
    J Clin Oncol; 1990 Feb; 8(2):203-8. PubMed ID: 2405105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate treatment of advanced head and neck cancers: a dose response evaluation.
    Woods RL; Fox RM; Tattersall MH
    Cancer Treat Rep; 1981; 65 Suppl 1():155-9. PubMed ID: 7034929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High dose methotrexate with CF rescue therapy in patients with head and neck cancer].
    Inuyama Y; Taketa C; Hiroto I; Fujii M; Takaoka T; Tanaka J; Matsuura S; Satake B; Takeoda S; Nishijima W
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1823-31. PubMed ID: 6332576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate-dose methotrexate in head and neck cancer.
    Advani SH; Mehta AR; Rao MR; Fakih AR; Sanghvi VD; Nair CN; Gopal R
    Oncology; 1981; 38(6):329-33. PubMed ID: 6975453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predefinitive and postdefinitive chemotherapy for locally advanced squamous carcinoma of the head and neck.
    Kirkwood JM; Miller D; Weichselbaum R; Pitman SW
    Laryngoscope; 1979 Apr; 89(4):573-81. PubMed ID: 311882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancer.
    Chang PM; Teng HW; Chen PM; Chang SY; Chu PY; Tsai TL; Tai SK; Wang YF; Huang JL; Yang MH
    J Chin Med Assoc; 2008 Jul; 71(7):336-41. PubMed ID: 18653395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial adjuvant weekly high dose methotrexate with leucovorin rescue in advanced squamous carcinoma of the head and neck.
    Weichselbaum RR; Miller D; Pitman SW; Kirkwood J
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):671-4. PubMed ID: 309465
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate and 5-fluorouracil in head and neck cancer.
    Ringborg U; Ewert G; Kinnman J; Lundquist PG; Strander H
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):20-2. PubMed ID: 6603022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Wright JE; Norris CM; Busse PM; Lucarini JW; Fallon BG; Casey D; Andersen JW; Klein R
    Ann Intern Med; 1990 Feb; 112(3):167-72. PubMed ID: 2297193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
    Vokes EE; Haraf DJ; McEvilly JM; Mick R; Kozloff MF; Goldman MD; Moran WJ; Clendeninn NJ; Collier MA; Weichselbaum RR
    Ann Oncol; 1992 Jan; 3(1):79-81. PubMed ID: 1606074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.